Aviva
GH icon

Aviva’s Guardant Health GH Stock Holding History

Aviva’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,848
Closed -$1.35M – 912
2021
Q1 		$1.35M Sell
8,848
-2,849
-24% -$431K 0.01% 741
2020
Q4 		$1.51M Sell
11,697
-9,484
-45% -$1.09M 0.01% 763
2020
Q3 		$2.37M Sell
21,181
-7,367
-26% -$674K 0.01% 634
2020
Q2 		$2.32M Sell
28,548
-24,214
-46% -$1.95M 0.01% 671
2020
Q1 		$3.67M Buy
+52,762
New +$4.05M 0.03% 548

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Aviva's GH Position: Q2 2021 in Review

Aviva sold out of Guardant Health (GH) in Q2 2021, closing a stake of 8,848 shares — an estimated $1.35M sold.

Aviva first reported a position in GH in Q1 2020 and held it in 5 quarters. The position peaked at $3.67M in Q1 2020. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Aviva reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 8,848 Guardant Health shares in Q2 2021, an estimated $1.35M.
  • Aviva first reported a position in Guardant Health in Q1 2020 and held it in 5 quarters.
  • Aviva's Guardant Health position peaked at $3.67M in Q1 2020.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.